Click here to close now.




















Welcome!

News Feed Item

Spasticity Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

Spasticity Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spasticity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spasticity to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spasticity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Spasticity Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Merz Pharma GmbH & Co. KgaA 36
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 36
GW Pharmaceuticals plc 37
Clinical Trial Overview of GW Pharmaceuticals plc 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Sun Pharma Advanced Research Company 39
Clinical Trial Overview of Sun Pharma Advanced Research Company 39
MediciNova, Inc. 40
Clinical Trial Overview of MediciNova, Inc. 40
Acorda Therapeutics, Inc. 41
Clinical Trial Overview of Acorda Therapeutics, Inc. 41
Concert Pharmaceuticals, Inc. 42
Clinical Trial Overview of Concert Pharmaceuticals, Inc. 42
Almirall, S.A. 43
Clinical Trial Overview of Almirall, S.A. 43
Clinical Trial Overview of Top Institutes / Government 44
Vanderbilt University 44
Clinical Trial Overview of Vanderbilt University 44
National Institute of Neurological Disorders and Stroke 45
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 45
University of Minnesota 46
Clinical Trial Overview of University of Minnesota 46
University of Alberta 47
Clinical Trial Overview of University of Alberta 47
Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
University of Manitoba 49
Clinical Trial Overview of University of Manitoba 49
Princess Margaret Hospital 50
Clinical Trial Overview of Princess Margaret Hospital 50
Center for Medicinal Cannabis Research 51
Clinical Trial Overview of Center for Medicinal Cannabis Research 51
Department of Health, UK 52
Clinical Trial Overview of Department of Health, UK 52
University Hospital of Mont-Godinne 53
Clinical Trial Overview of University Hospital of Mont-Godinne 53
Five Key Clinical Profiles 54
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 119

List of Tables

Spasticity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 33
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014* 35
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 36
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 37
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014* 39
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014* 40
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 41
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Concert Pharmaceuticals, Inc., 2014* 42
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Almirall, S.A., 2014* 43
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 44
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 45
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 46
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014* 47
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 48
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 49
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2014* 50
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Medicinal Cannabis Research, 2014* 51
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 52
Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Mont-Godinne, 2014* 53

List of Figures

Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 118


Read the full report:
Spasticity Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Red Hat is investing in Tesora, the number one contributor to OpenStack Trove Database as a Service (DBaaS) also ranked among the top 20 companies contributing to OpenStack overall. Tesora, the company bringing OpenStack Trove Database as a Service (DBaaS) to the enterprise, has announced that Red Hat and others have invested in the company as a part of Tesora's latest funding round. The funding agreement expands on the ongoing collaboration between Tesora and Red Hat, which dates back to Febr...
SYS-CON Events announced today that DataClear Inc. will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. The DataClear ‘BlackBox’ is the only solution that moves your PC, browsing and data out of the United States and away from prying (and spying) eyes. Its solution automatically builds you a clean, on-demand, virus free, new virtual cloud based PC outside of the United States, and wipes it clean...
WSM International, the pioneer and leader in server migration services, has announced an agreement with WHOA.com, a leader in providing secure public, private and hybrid cloud computing services. Under terms of the agreement, WSM will provide migration services to WHOA.com customers to relocate some or all of their applications, digital assets, and other computing workloads to WHOA.com enterprise-class, secure cloud infrastructure. The migration services include detailed evaluation and planning...
Cloud and datacenter migration innovator AppZero has joined the Microsoft Enterprise Cloud Alliance Program. AppZero is a fast, flexible way to move Windows Server applications from any source machine – physical or virtual – to any destination server, in any cloud or datacenter, using its patented container technology. AppZero’s container is also called a Virtual Application Appliance (VAA). To facilitate Microsoft Azure onboarding, AppZero has two purpose-built offerings: AppZero SP for Azure,...
SYS-CON Events announced today that G2G3 will exhibit at SYS-CON's @DevOpsSummit Silicon Valley, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Based on a collective appreciation for user experience, design, and technology, G2G3 is uniquely qualified and motivated to redefine how organizations and people engage in an increasingly digital world.
SYS-CON Events announced today that IceWarp will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. IceWarp, the leader of cloud and on-premise messaging, delivers secured email, chat, documents, conferencing and collaboration to today's mobile workforce, all in one unified interface
In 2014, the market witnessed a massive migration to the cloud as enterprises finally overcame their fears of the cloud’s viability, security, etc. Over the past 18 months, AWS, Google and Microsoft have waged an ongoing battle through a wave of price cuts and new features. For IT executives, sorting through all the noise to make the best cloud investment decisions has become daunting. Enterprises can and are moving away from a "one size fits all" cloud approach. The new competitive field has ...
In his session at @ThingsExpo, Lee Williams, a producer of the first smartphones and tablets, will talk about how he is now applying his experience in mobile technology to the design and development of the next generation of Environmental and Sustainability Services at ETwater. He will explain how M2M controllers work through wirelessly connected remote controls; and specifically delve into a retrofit option that reverse-engineers control codes of existing conventional controller systems so the...
Everyone talks about continuous integration and continuous delivery but those are just two ends of the pipeline. In the middle of DevOps is continuous testing (CT), and many organizations are struggling to implement continuous testing effectively. After all, without continuous testing there is no delivery. And Lab-As-A-Service (LaaS) enhances the CT with dynamic on-demand self-serve test topologies. CT together with LAAS make a powerful combination that perfectly serves complex software developm...
The Internet of Things is in the early stages of mainstream deployment but it promises to unlock value and rapidly transform how organizations manage, operationalize, and monetize their assets. IoT is a complex structure of hardware, sensors, applications, analytics and devices that need to be able to communicate geographically and across all functions. Once the data is collected from numerous endpoints, the challenge then becomes converting it into actionable insight.
With the proliferation of connected devices underpinning new Internet of Things systems, Brandon Schulz, Director of Luxoft IoT – Retail, will be looking at the transformation of the retail customer experience in brick and mortar stores in his session at @ThingsExpo. Questions he will address include: Will beacons drop to the wayside like QR codes, or be a proximity-based profit driver? How will the customer experience change in stores of all types when everything can be instrumented and a...
Enterprises can achieve rigorous IT security as well as improved DevOps practices and Cloud economics by taking a new, cloud-native approach to application delivery. Because the attack surface for cloud applications is dramatically different than for highly controlled data centers, a disciplined and multi-layered approach that spans all of your processes, staff, vendors and technologies is required. This may sound expensive and time consuming to achieve as you plan how to move selected applicati...
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
This Enterprise Strategy Group lab validation report of the NEC Express5800/R320 server with Intel® Xeon® processor presents the benefits of 99.999% uptime NEC fault-tolerant servers that lower overall virtualized server total cost of ownership. This report also includes survey data on the significant costs associated with system outages impacting enterprise and web applications. Click Here to Download Report Now!
Consumer IoT applications provide data about the user that just doesn’t exist in traditional PC or mobile web applications. This rich data, or “context,” enables the highly personalized consumer experiences that characterize many consumer IoT apps. This same data is also providing brands with unprecedented insight into how their connected products are being used, while, at the same time, powering highly targeted engagement and marketing opportunities. In his session at @ThingsExpo, Nathan Trel...